VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
RDGTRidgetech Inc.
$1.37$356
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksRDGTP/E History

RDGT logoRidgetech Inc. (RDGT) P/E Ratio History

Deep Value

Trading at 0.0x · of 5-year range · Significant discount to historical valuation · Data 2011–2017

Current P/E (TTM)
0.0x
-100% vs 5Y avg
5Y Avg P/E
0.0x
Median 0.0x
5Y Percentile
N/A
PEG Ratio
N/A
5-Year P/E Range
0.0x
Min0.0xMedian0.0xMax0.1x
TTM EPS$26247.31
Price$1.37
Earnings Yield100.00%
EPS Growth (1Y)162.8%
EPS Growth (5Y)N/A

Loading P/E history...

P/E Ratio Analysis

As of June 22, 2026, Ridgetech Inc. (RDGT) trades at a price-to-earnings ratio of 0.0x, with a stock price of $1.37 and trailing twelve-month earnings per share of $26247.31.

The current P/E is 100% below its 5-year average of 0.0x. Over the past five years, RDGT's P/E has ranged from a low of 0.0x to a high of 0.1x, placing the current valuation at the nullth percentile of its historical range.

Compared to the Healthcare sector median P/E of 22.1x, RDGT trades at a 100% discount to its sector peers. The sector includes 233 companies with P/E ratios ranging from 0.0x to 194.5x.

Relative to the broader market, RDGT trades at a notable discount to the S&P 500 median P/E of 24.3x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.

For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our RDGT DCF Valuation Calculator →

Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.

RDGT Cross-Benchmark Valuation

How does the current P/E compare to sector peers and the broader market?

vs. Healthcare
0.0vs22.1
-100%
Below Sector
vs. S&P 500
0.0vs24.3
-100%
Below Market
PEG Analysis
N/A
P/E ÷ EPS Growth
Based on 163% EPS growth (1Y)

RDGT P/E vs Peers

Drug Wholesalers and Distributors peers sorted by market cap

CompanyMarket CapP/E RatioPEG RatioEPS Growth (1Y)
MCK logoMCKMcKesson Corporation
$90B19.4-+49%
COR logoCORCencora, Inc.
$53B34.1-+6%
CAH logoCAHCardinal Health, Inc.
$52B34.5-+87%Best
PBH logoPBHPrestige Consumer Healthcare Inc.
$2B11.6Lowest3.19Best-9%

Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.

RDGT Historical P/E Data (2011–2017)

Quarterly P/E ratios calculated from closing price and TTM EPS

QuarterPeriod EndPriceTTM EPSP/E Ratiovs Avg
FY2017 Q2Sep 30 2016$64080.00$746100.000.1x+105%
FY2016 Q4-$57600.00$679050.000.1x+103%
FY2013 Q2Sep 30 2012$24498.00$1700100.000.0x-66%
FY2012 Q4Mar 31 2012$43560.00$2942100.000.0x-65%
FY2012 Q2Sep 30 2011$50400.00$3269799.000.0x-63%
FY2011 Q4-$93960.00$2610774.000.0x-14%

Average P/E for displayed period: 0.0x

Export Data
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

15+ years return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

RDGT — Frequently Asked Questions

Quick answers to the most common questions about buying RDGT stock.

What is RDGT's P/E ratio?

Ridgetech Inc. (RDGT) trailing twelve-month P/E ratio is 0.0x, based on TTM diluted EPS of $26247.31. The 5-year average P/E is 0.0x and the historical range spans 0.0x to 0.1x.

Is RDGT stock overvalued or undervalued?

RDGT current P/E: 0.0x. 5-year average P/E: 0.0x. Percentile: N/A.

Is RDGT stock expensive?

RDGT is fairly valued relative to its own history. The current P/E of 0.0x is near the 5-year average of 0.0x (N/A percentile of historical range).

What is RDGT's historical P/E range?

Over the past 5 years, RDGT's P/E ratio has ranged from 0.0x to 0.1x, with a median of 0.0x and an average of 0.0x. The current P/E of 0.0x places the stock at the N/A percentile of this range. Full historical data spans 2011–2017.

How does RDGT's P/E compare to the S&P 500?

RDGT current P/E: 0.0x. S&P 500 median P/E: 24.3x.

How does RDGT's valuation compare to Healthcare peers?

Ridgetech Inc. P/E of 0.0x can be benchmarked against Healthcare peers in the comparison table on this page.

What is RDGT's PEG ratio?

RDGT PEG ratio is N/A, based on a P/E of 0.0x and EPS growth of 162.8%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.

What is RDGT's earnings yield?

RDGT earnings yield is 100.00%, the inverse of its 0.0x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.

RDGT P/E Ratio History (2011–2017)

Quarterly valuation multiple from closing price and trailing EPS

Current0.1x
Period Avg0.0x
Range0.0x - 0.1x
Change+139%
6 quartersMar 31, 2011 - Sep 30, 2016